undefined undefined
NaN.000
NaN.00%
Gainers CareCloud (NASDAQ:CCLD) stock moved upwards by 80.5% to $2.27 during M...
05-14 00:31
Benitec press release (NASDAQ:BNTC): Q3 GAAP EPS of -$1.64. Net loss attributable to shareholders was $4.3 million, compared to a net loss of $4.4 million a year-ago. As of March 31, the company had $...
05-13 22:28
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(1.64) per share which missed the analyst consensus estimate of $(0.78) by 110.26 percent.
05-13 20:18
摩根大通证券公司:维持Benitec Biopharma(BNTC.US)评级,由优于大市调整至优于大市评级, 目标价由10.00美元调整至16.00美元。
04-23 00:20
JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the price target from $10 to $16.
04-23 00:17
Gainers: Bio-Path Holdings (BPTH) +69%. Aileron Therapeutics (ALRN) +51%. SINTX Technologies (SINT) +42%. Expion360 (XPON) +30%. Swvl Holdings Corp (SWVL) +27%. MicroCloud Hologram (HOLO) +27%. Mawson...
04-19 00:42
Gainers: Bio-Path Holdings (BPTH) +89%. Sintx Technologies (SINT) +79%. Aileron Therapeutics (ALRN) +37%. Benitec Biopharma (BNTC) +29%. Intelligent Bio Solutions (INBS) +19%. Losers: NRx Pharmaceutic...
04-18 22:00
Gainers: Bio-Path Holdings (BPTH) +61% Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients...
04-18 20:40
BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in Phase 1/1b clinical trial of BP1002 evaluating the ability of BP1002 to treat
04-18 20:35